It can be used by those working on 3D cell cultures, organoids, single-cell analysis and other applications.
The company is now focusing on the commercial roll-out.
Dr Shankar Balasubramanian and Dr David Klenerman also discuss the possibility of $100 genome sequencing.
Homes, shops, restaurants and green space will be integrated alongside hospitals and world-leading life science work.
It will accelerate the roll-out of products.
They were among 63 honoured.
The Cambridge Science Park company’s Series A financing has totalled $33m.
STORM Therapeutics aims for clinical trials in 2022.
Its lead product can target bacteria in the lungs without damaging other cells.
It will receive $20m upfront.
Fourteen categories celebrated extraordinary talent, from biotech to AI.
The company has won Start-up of the Year at the Cambridge Independent Science and Technology Awards.
A limited number of tickets are now on sale.
Biotech’s targets include chronic pain, depression, epilepsy and anxiety
CEO Sarah Howell is nominated as CEO of the Year at the Cambridge Independent Science and Technology Awards.
He has been acting director since the death of Prof Michael Wakelam.